We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Oncology drugs.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Oncology drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Oncology drugs Product List

1~3 item / All 3 items

Displayed results

[Research Material] Global Market for Antitumor Therapy

Global Market for Antitumor Therapy: Chemotherapeutic Agents, Immunotherapeutic Agents, Personalized Medicine, Hospitals, Clinics, Cancer Rehabilitation Centers, Outpatient Surgery Centers

This research report (Global Anti-Neoplastic Therapy Market) investigates and analyzes the current state and outlook for the global market of anti-neoplastic therapy over the next five years. It includes information on the overview of the global anti-neoplastic therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-neoplastic therapy market focus on chemotherapy agents, immunotherapy agents, and personalized medicine, while the segments by application target hospitals, clinics, cancer rehabilitation centers, and outpatient surgery centers. The regional segments calculate the market size for anti-neoplastic therapy divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in anti-neoplastic therapy, product and business overviews, and sales performance.

  • Other services
  • Oncology drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Synovial Sarcoma Treatment

World Market for Synovial Sarcoma Treatment: ACXT-3102, AL-3818, Axi-cabtagene ciloleucel, CMB-305, CUE-102, others, hospitals, ...

This research report (Global Synovial Sarcoma Treatment Market) investigates and analyzes the current state and outlook for the global market for synovial sarcoma treatment over the next five years. It includes information on the overview of the global synovial sarcoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include ACXT-3102, AL-3818, Axitinib, CMB-305, CUE-102, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for synovial sarcoma treatment. It also includes the market share of major companies in the synovial sarcoma treatment sector, product and business overviews, and sales performance.

  • Other services
  • Oncology drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Glioblastoma Treatment Drugs

World Market for Glioblastoma Treatment Drugs: VEGF/VEGFR Inhibitors, Alkylating Agents, Other Antitumor Drugs, Hospitals, Cancer Research Organizations, Long-term Care Centers ...

This research report (Global Glioblastoma Treatment Drugs Market) investigates and analyzes the current state and outlook for the global market for glioblastoma treatment drugs over the next five years. It includes information on the overview of the global glioblastoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include VEGF/VEGFR inhibitors, alkylating agents, and other antitumor drugs, while the segments by application focus on hospitals, cancer research institutions, long-term care centers, and diagnostic centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for glioblastoma treatment drugs. It also includes the market share of major companies in glioblastoma treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Oncology drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration